Vimarsana
Biggest News Aggregation in the World

Page 25 - Iagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iagnostics Today - Breaking & Trending Today

Consortium awards Second Contract for Biopsy Diagnostics - Vimarsana News

Consortium awards Second Contract for Biopsy Diagnostics

A partnership comprising software company Euformatics, ViennaLab Diagnostics and Oncompass Medicine, have been awarded with one of three Phase 2 contracts to research and develop an economically sustainable liquid biopsy diagnostics solution based on DNA and RNA molecular profiling in cancer patients for a buyer consortium including some of the highest ranking European hospitals(1) from Germany, France, Italy, Spain and Belgium for the OncNGS pre-commercial procurement Consortium funded by the EU. Click to read more...

Blood test for pan-cancer biomarker could revolutionize early cancer detection - Vimarsana News

Blood test for pan-cancer biomarker could revolutionize early cancer detection

Diagnostic tools for timely, accurate and inexpensive early cancer detection that can assess risk or monitor response to treatment could help patients get the care they need faster and improve existing care strategies.

Breast cancer screening event comes to Purchase area - Vimarsana News

Breast cancer screening event comes to Purchase area

The key to cancer survival rates is closely tied to early detection, and at the Purchase District Health Department, they are helping people locally get access to the most advanced

Invitae's First of Its Kind Cancer Test Receives FDA Marketing Authorization - Vimarsana News

Invitae's First of Its Kind Cancer Test Receives FDA Marketing Authorization

The FDA awarded marketing authorization for a new Invitae test that uses next-generation sequencing to assess multiple genes to identify variants indicating a person’s predisposition for certain cancers. The regulatory action creates a new regulatory classification making Invitae’s test the predicate device for future cancer tests.

Global Scleroderma Diagnostics and Therapeutics Market - Vimarsana News

Global Scleroderma Diagnostics and Therapeutics Market

Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The